Cargando…
Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge
The ongoing global Monkeypox outbreak that started in the spring of 2022 has reinforced the importance of protecting the population using live virus vaccines based on the vaccinia virus (VACV). Smallpox also remains a biothreat and although some U.S. military personnel are immunized with VACV, safet...
Autores principales: | Noyce, Ryan S., Westfall, Landon W., Fogarty, Siobhan, Gilbert, Karen, Mpanju, Onesmo, Stillwell, Helen, Esparza, José, Daugherty, Bruce, Koide, Fusataka, Evans, David H., Lederman, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965234/ https://www.ncbi.nlm.nih.gov/pubmed/36851570 http://dx.doi.org/10.3390/v15020356 |
Ejemplares similares
-
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates
por: Awasthi, Mayanka, et al.
Publicado: (2023) -
Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments
por: Noyce, Ryan S., et al.
Publicado: (2018) -
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits
por: Awasthi, Mayanka, et al.
Publicado: (2023) -
Synthetic horsepox viruses and the continuing debate about dual use research
por: Noyce, Ryan S., et al.
Publicado: (2018) -
Re-assembly of nineteenth-century smallpox vaccine genomes reveals the contemporaneous use of horsepox and horsepox-related viruses in the USA
por: Brinkmann, Annika, et al.
Publicado: (2020)